Published in Virology on May 01, 1982
Assembly of gag-beta-galactosidase proteins into retrovirus particles. J Virol (1990) 2.99
Regulated expression of a complete human beta-globin gene encoded by a transmissible retrovirus vector. Mol Cell Biol (1987) 2.77
Tunicamycin treatment of CHO cells abrogates multiple blocks to retrovirus infection, one of which is due to a secreted inhibitor. J Virol (1992) 2.45
Viral and cellular factors governing hamster cell infection by murine and gibbon ape leukemia viruses. J Virol (1991) 2.18
Susceptibility of wild mouse cells to exogenous infection with xenotropic leukemia viruses: control by a single dominant locus on chromosome 1. J Virol (1985) 1.95
Role of reticuloendotheliosis virus envelope glycoprotein in superinfection interference. J Virol (1989) 1.83
Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes. J Virol (1988) 1.75
Friend spleen focus-forming virus induces factor independence in an erythropoietin-dependent erythroleukemia cell line. J Virol (1990) 1.66
Mutational analysis of the N-linked glycosylation sites of the SU envelope protein of Moloney murine leukemia virus. J Virol (1992) 1.64
Inhibitors of retrovirus infection are secreted by several hamster cell lines and are also present in hamster sera. J Virol (1993) 1.49
Cell-surface receptors for retroviruses and implications for gene transfer. Proc Natl Acad Sci U S A (1996) 1.30
Fibroblasts transfected with Torpedo acetylcholine receptor beta-, gamma-, and delta-subunit cDNAs express functional receptors when infected with a retroviral alpha recombinant. J Cell Biol (1989) 1.20
Infection of immune mast cells by Harvey sarcoma virus: immortalization without loss of requirement for interleukin-3. Mol Cell Biol (1985) 1.20
Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells. Proc Natl Acad Sci U S A (1987) 1.20
A retrovirus expressing the 12S adenoviral E1A gene product can immortalize epithelial cells from a broad range of rat tissues. Mol Cell Biol (1988) 1.13
A phenotypic host range alteration determines RD114 virus restriction in feline embryonic cells. J Virol (1993) 1.10
Liposome encapsulation of retrovirus allows efficient superinfection of resistant cell lines. J Virol (1984) 1.04
Gibbon ape leukemia virus receptor functions of type III phosphate transporters from CHOK1 cells are disrupted by two distinct mechanisms. J Virol (1999) 1.00
v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer. Proc Natl Acad Sci U S A (1988) 0.99
Insertion of the v-Ha-ras oncogene induces differentiation of calcitonin-producing human small cell lung cancer. J Clin Invest (1989) 0.98
v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell line. J Clin Invest (1990) 0.95
Expression of the Saccharomyces cerevisiae glycoprotein invertase in mouse fibroblasts: glycosylation, secretion, and enzymatic activity. Proc Natl Acad Sci U S A (1987) 0.91
Differential glycosylation of the Cas-Br-E env protein is associated with retrovirus-induced spongiform neurodegeneration. J Virol (2000) 0.89
Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc Natl Acad Sci U S A (1986) 7.02
Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc Natl Acad Sci U S A (1988) 6.44
Rapid cell culture assay technic for murine leukaemia viruses. Nature (1971) 5.87
Isolation of murine sarcoma virus-transformed mouse cells which are negative for leukemia virus from agar suspension cultures. Int J Cancer (1970) 5.48
Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J Virol (1990) 5.45
Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity. Virology (1985) 4.65
Analysis of the ribonucleic acid of murine leukemia virus. J Virol (1969) 4.32
In vivo modification of retroviral gag gene-encoded polyproteins by myristic acid. J Virol (1983) 4.09
Amino terminal myristylation of the protein kinase p60src, a retroviral transforming protein. Science (1985) 3.97
Effects of local cell concentrations upon the growth of chick embryo cells in tissue culture. Exp Cell Res (1968) 3.94
Interference grouping of murine leukemia viruses: a distinct receptor for the MCF-recombinant viruses in mouse cells. Virology (1982) 3.86
Maturation of dimeric viral RNA of Moloney murine leukemia virus. J Virol (1993) 3.78
Sequence analysis of amphotropic and 10A1 murine leukemia viruses: close relationship to mink cell focus-inducing viruses. J Virol (1990) 3.77
Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions. J Virol (1994) 3.54
RNA is a structural element in retrovirus particles. Proc Natl Acad Sci U S A (2001) 3.45
In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J Virol (1999) 3.34
The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J Virol (1993) 3.29
Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. Proc Natl Acad Sci U S A (1998) 3.24
Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med (1989) 3.03
Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses. J Virol (2000) 2.98
Unmyristylated Moloney murine leukemia virus Pr65gag is excluded from virus assembly and maturation events. J Virol (1989) 2.90
Different recombinant murine leukemia viruses use different cell surface receptors. Virology (1984) 2.85
Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne). J Virol (1988) 2.76
Basis for receptor specificity of nonecotropic murine leukemia virus surface glycoprotein gp70SU. J Virol (1992) 2.61
Synthesis and circularization of N- and B-tropic retroviral DNA Fv-1 permissive and restrictive mouse cells. Proc Natl Acad Sci U S A (1980) 2.45
Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes. Proc Natl Acad Sci U S A (1983) 2.44
Phenotypic mixing between N- and B-tropic murine leukemia viruses: infectious particles with dual sensitivity to Fv-1 restriction. Cell (1976) 2.34
Murine leukemia virus mutant with a frameshift in the reverse transcriptase coding region: implications for pol gene structure. J Virol (1984) 2.32
HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro. Proc Natl Acad Sci U S A (1996) 2.30
Transformation of mouse 3T3 cells by murine sarcoma virus: release of virus-like particles in the absence of replicating murine leukemia helper virus. Proc Natl Acad Sci U S A (1971) 2.26
Murine sarcoma virus (Harvey): characteristics of focus formation in mouse embryo cell cultures, and virus production by hamster tumor cells. Int J Cancer (1968) 2.24
Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue. J Virol (1998) 2.18
Post-translational modification of Rauscher leukemia virus precursor polyproteins encoded by the gag gene. J Virol (1979) 2.16
Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science (1995) 2.16
Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides. J Virol (1998) 2.14
A replication-defective variant of Moloney murine leukemia virus. I. Biological characterization. J Virol (1978) 2.09
Modulation of HIV-like particle assembly in vitro by inositol phosphates. Proc Natl Acad Sci U S A (2001) 2.07
Normal DBA/2 mouse cells synthesize a glycoprotein which interferes with MCF virus infection. Virology (1982) 2.02
Temperature-dependent transformation of cells infected with a mutant of Bryan Rous sarcoma virus. J Virol (1972) 2.01
Loss of Fv-1 restriction in Balb/3T3 cells following infection with a single N tropic murine leukemia virus particle. Cell (1977) 1.95
Translational suppression in retroviral gene expression. Adv Virus Res (1992) 1.93
Mutant of B-tropic murine leukemia virus synthesizing an altered polymerase molecule. J Virol (1979) 1.90
Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes. Mol Cell Biol (1985) 1.85
Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. J Virol (1996) 1.83
Murine leukemia virus gag polyproteins: the peptide chain unique to Pr80 is located at the amino terminus. Virology (1978) 1.73
Viral ribonucleic acid polymerase: chick-embryo cells infected with vesicular stomatitis virus or Rous-associated virus. Biochim Biophys Acta (1965) 1.71
Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes. Proc Natl Acad Sci U S A (1989) 1.69
Metabolic requirements for infection by Rous sarcoma virus. I. The transient requirement for DNA synthesis. Virology (1966) 1.69
Murine sarcoma virus pseudotypes acquire a determinant specifying N or B tropism from leukaemia virus during rescue. Nature (1975) 1.68
Electron microscopic observations on the ribonucleic acid of murine leukemia virus. J Virol (1969) 1.67
Dual susceptibility of A 3T3 mouse cell line to infection by N- and B-tropic murine leukemia virus: apparent lack of expression of the FV-1 gene. Int J Cancer (1974) 1.65
Detection of the myristylated gag-raf transforming protein with raf-specific antipeptide sera. Virology (1985) 1.64
Control of acute Zollinger-Ellison syndrome with intravenous omeprazole. Lancet (1982) 1.63
Revertants of mouse cells transformed by murine sarcoma virus. I. Characterization of flat and transformed sublines without a rescuable murine sarcoma virus. Virology (1972) 1.59
Studies on the fixation and development of cellular transformation by Rous sarcoma virus. Virology (1968) 1.57
Hydroxylamine-stable covalent linkage of myristic acid in G0 alpha, a guanine nucleotide-binding protein of bovine brain. Biochem Biophys Res Commun (1987) 1.55
Donation of N- or B-tropic phenotype to NB-tropic murine leukemia virus during mixed infections. J Virol (1977) 1.52
Maturation of murine leukemia virus env proteins in the absence of other viral proteins. Virology (1985) 1.49
Chromatographic analysis of the aminoacyl-tRNAs which are required for translation of codons at and around the ribosomal frameshift sites of HIV, HTLV-1, and BLV. Virology (1989) 1.47
Induction of mutations in an RNA tumour virus by an analogue of a DNA precursor. Nat New Biol (1971) 1.46
A change in growth potential of cells after conversion by Rous sarcoma virus. J Cell Physiol (1967) 1.45
Identification of amino acids inserted during suppression of UAA and UGA termination codons at the gag-pol junction of Moloney murine leukemia virus. Proc Natl Acad Sci U S A (1990) 1.45
Comparison of murine sarcoma viruses in nonproducer and S + L - -transformed cells. J Virol (1972) 1.44
Poorly expressed endogenous ecotropic provirus of DBA/2 mice encodes a mutant Pr65gag protein that is not myristylated. J Virol (1988) 1.43
Isolation of human amnion cells transformed by rescuable murine sarcoma virus. Nat New Biol (1973) 1.41
Structure of glycosylated and unglycosylated gag polyproteins of Rauscher murine leukemia virus: carbohydrate attachment sites. J Virol (1981) 1.39
Characteristics of cores of avian leuko-sarcoma viruses. Virology (1970) 1.36
Accumulation of water during transformation of cells by an avian sarcoma virus. Cell (1974) 1.35
An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate detectable mink cell focus-inducing virus in vivo. Proc Natl Acad Sci U S A (1991) 1.35
Placement of tRNA primer on the primer-binding site requires pol gene expression in avian but not murine retroviruses. J Virol (1997) 1.34
Production of virus by mammalian cells tranformed by Rous sarcoma and murine sarcoma viruses. J Virol (1968) 1.34
Phenotypes of murine leukemia virus-induced tumors: influence of 3' viral coding sequences. J Virol (1992) 1.33
Rescue of murine sarcoma virus from a sarcoma-positive leukemia-negative cell line: requirement for replicating leukemia virus. J Virol (1971) 1.32
Suppression of UAA and UGA termination codons in mutant murine leukemia viruses. J Virol (1989) 1.32
Characterization of the block in replication of nucleocapsid protein zinc finger mutants from moloney murine leukemia virus. J Virol (1999) 1.32
Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. Science (1987) 1.30
The envelope proteins of bovine leukemia virus: purification and sequence analysis. Virology (1984) 1.29
Synthesis of the RNA of RNA-containing tumor viruses. I. The interval between synthesis and envelopment. Virology (1970) 1.29
Translational readthrough of the murine leukemia virus gag gene amber codon does not require virus-induced alteration of tRNA. J Virol (1989) 1.28
Transformation by murine sarcoma virus: fixation (deoxyribonucleic acid synthesis) and development. J Virol (1968) 1.28
The safety profile of De-Nol. Digestion (1987) 1.26
Rescue and transmission of a replication-defective variant of moloney murine leukemia virus. J Virol (1979) 1.25
Biological, chemical, and immunological studies of Rauscher ecotropic and mink cell focus-forming viruses from JLS-V9 cells. J Virol (1983) 1.25
Infection of immune mast cells by Harvey sarcoma virus: immortalization without loss of requirement for interleukin-3. Mol Cell Biol (1985) 1.20
Tunicamycin inhibits glycosylation of precursor polyprotein encoded by env gene of Rauscher murine leukemia virus. Biochem Biophys Res Commun (1979) 1.19
Reversion of murine sarcoma virus transformed mouse cells: variants without a rescuable sarcoma virus. Science (1972) 1.18